Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | HPGD | P15428 | 6/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA1 | P00915 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | CA9 | Q16790 | 3/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | HMGB1 | P09429 | 1/20 | 1.00 |
| ▸ | CA4 | P22748 | 1/20 | 1.00 |
| ▸ | CA6 | P23280 | 1/20 | 1.00 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | G6PD | P11413 | 1/20 | 0.60 |
| ▸ | CASP7 | P55210 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicylic Acid SCHEMBL17156443 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL8433746 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL29360246 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL29606432 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL1509155 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL1967 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL9982 | 0.97 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL299754 | 0.97 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL546853 | 0.97 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDCA12CA1 | |
| Salicylic Acid SCHEMBL12477692 | 0.97 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4173929-B1 | VEHICLE-BODY STRUCTURE | MAZDA MOTOR (JP) | 2025-10-08 | — | — | EP | claimed |
| EP-4466045-B1 | DRY POWDER INHALATION DEVICE | MERXIN LTD (GB) | 2025-09-17 | — | — | EP | claimed |
| US-20250144016-A1 | Soft Chews with Low Water Activity and Methods of Manufacturing Same | FLORIDA RESEARCH GROUP LLC | 2025-05-08 | — | — | US | claimed |
| EP-4528093-A1 | AIRCRAFT NACELLE PROVIDED WITH AT LEAST ONE THRUST REVERSER DEVICE COMPRISING AT LEAST ONE LONGITUDINAL DEFLECTOR, AIRCRAFT COMPRISING AT LEAST ONE PROPULSION ASSEMBLY COMPRISING SUCH A NACELLE | AIRBUS OPERATIONS (S.A.S.) (FR) | 2025-03-26 | — | — | EP | claimed |
| US-12194144-B2 | Soft chews with low water activity and methods of manufacturing same | FLORIDA RESEARCH GROUP LLC (US) | 2025-01-14 | — | — | US | claimed |
| EP-4222299-B1 | REUSABLE MOISTURE-REGULATING TEXTILE SHEET | MEDICAL SYSTEM PROTECT GMBH (DE) | 2024-11-06 | — | — | EP | claimed |
| EP-4067250-B1 | PACKAGING SYSTEM | NAKURU S R L (IT) | 2024-06-26 | — | — | EP | claimed |
| WO-2024123166-A1 | MODULAR SYSTEM MADE OF STRUCTURAL ALUMINUM FOR A SOLAR PANEL BASE | SALAZAR NAVA DANIEL FRANCISCO (MX) | 2024-06-13 | — | — | WO | claimed |
| EP-4341106-A1 | METHOD FOR MONITORING AN AIRCRAFT LANDING GEAR EMPLOYING AT LEAST ONE ACCELEROMETER SUPPORTED BY A WHEEL OF THE LANDING GEAR, AND AIRCRAFT IMPLEMENTING THIS METHOD | Safran Landing Systems (FR) | 2024-03-27 | — | — | EP | claimed |
| CN-113351373-B | Floatation collector for diaspore ore and preparation method and application thereof | 中国地质科学院矿产综合利用研究所 | 2023-05-12 | — | — | CN | claimed |
| EP-4146619-A1 | PRODUCTION OF JASMONATES IN FILAMENTOUS FUNGI | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-03-15 | — | — | EP | claimed |
| WO-2022243392-A1 | METHOD FOR MONITORING AN AIRCRAFT LANDING GEAR EMPLOYING AT LEAST ONE ACCELEROMETER SUPPORTED BY A WHEEL OF THE LANDING GEAR, AND AIRCRAFT IMPLEMENTING THIS METHOD | SAFRAN LANDING SYSTEMS (FR) | 2022-11-24 | — | — | WO | claimed |
| WO-2022238607-A1 | NOSE FITTING DEVICE FOR AIR FILTRATION FACE MASKS | MARTINEZ ALBAL ELOY ANTONIO (ES) | 2022-11-17 | — | — | WO | claimed |
| EP-3471636-B1 | INTERNAL PLATE FIXATION DEVICE | ORTHOFIX SRL (IT) | 2022-08-03 | — | — | EP | claimed |
| US-20220218644-A1 | METHOD AND COMPOSITION FOR TREATING OSTEOARTHRITIS | VIREO SYSTEMS, INC. (US) | 2022-07-14 | — | — | US | claimed |
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | CLEARSIDE BIOMEDICAL, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4746869-A2 | MODULATORS OF NEURODEGENERATION | The General Hospital Corporation (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2022023885-A2 | VERTICAL TRAY WAREHOUSE | MODULA S.P.A. (IT) | 2022-02-03 | — | — | WO | disclosed |
| US-20220033832-A1 | MODIFIED AOX1 PROMOTER VARIANTS | ORTA DOGU TEKNIK UNIVERSITESI (TR) | 2022-02-03 | — | — | US | disclosed |
| CN-113993848-A | Inhibitors of PAPD5 and methods of use thereof | 儿童医学中心公司 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | PROKR2, SLC10A2, GLP1R | ALDH1A1 4190/4885KDM4E 4530/4885HPGD 4139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.